• レポートコード:QY20ST-06657 • 出版社/出版日:QYResearch / 2020年9月25日 ※2025年版があります。お問い合わせください。 • レポート形態:英文、PDF、131ページ • 納品方法:Eメール(受注後2~3営業日) • 産業分類:医療機器・消耗品 |
Single User | ¥560,000 (USD4,000) | ▷ お問い合わせ |
Multi User | ¥840,000 (USD6,000) | ▷ お問い合わせ |
Enterprise License | ¥1,120,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートでは、世界の末梢動脈疾患用薬剤溶出バルーン市場について種類別(3μg/ mm2、2μg / mm2、その他)、用途別(病院、外来手術センター、カテーテル検査室、その他)、地域別(北米、ヨーロッパ、中国、日本、東南アジア、インド)に区分して調査し、纏めました。2015年~2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・末梢動脈疾患用薬剤溶出バルーン市場の概要 ・世界の主要地域別末梢動脈疾患用薬剤溶出バルーン市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界の末梢動脈疾患用薬剤溶出バルーン市場規模2015-2026:種類別(3μg/ mm2、2μg / mm2、その他) ・世界の末梢動脈疾患用薬剤溶出バルーン市場規模2015-2026:用途別(病院、外来手術センター、カテーテル検査室、その他) ・末梢動脈疾患用薬剤溶出バルーンの北米市場規模2015-2020 ・末梢動脈疾患用薬剤溶出バルーンのヨーロッパ市場規模2015-2020 ・末梢動脈疾患用薬剤溶出バルーンの中国市場規模2015-2020 ・末梢動脈疾患用薬剤溶出バルーンの日本市場規模2015-2020 ・末梢動脈疾患用薬剤溶出バルーンの東南アジア市場規模2015-2020 ・末梢動脈疾患用薬剤溶出バルーンのインド市場規模2015-2020 ・主要プレイヤーの企業情報:事業概要・売上・企業動向 ・末梢動脈疾患用薬剤溶出バルーンの製造コスト分析 ・販売チャネル、流通業者、顧客 ・末梢動脈疾患用薬剤溶出バルーンの市場動向・機会・課題 ・調査の結論 |
A recently published report by QY Research titled Global Drug Eluting Balloon for Peripheral Artery Disease Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate data in a statistical manner. It examines the historic accomplishments and recent opportunities present in the global Drug Eluting Balloon for Peripheral Artery Disease market. QY Research report focuses on the consumption, geography, by type, by application, and the competitive landscape. The 4000 version of the report mainly splits the data for each region to analyze the leading companies, applications, and product types.
QY Research aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Report Overview:
A drug eluting balloon is a semi-compliant angioplasty balloon that is surrounded by an anti-proliferative medicine. The medicine is ejected to the vessel wall during the inflation of the balloon. The active substance of the balloon is highly lipophilic (dissolved in lipids or fats). The drug eluting balloon homogeneously delivers the drug to the vessel and provides treatment for peripheral artery disease.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Drug Eluting Balloon for Peripheral Artery Disease market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Drug Eluting Balloon for Peripheral Artery Disease industry.
Based on our recent survey, we have several different scenarios about the Drug Eluting Balloon for Peripheral Artery Disease YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Drug Eluting Balloon for Peripheral Artery Disease will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
QY Research report provides an overview and scope of the global Drug Eluting Balloon for Peripheral Artery Disease market, stating its drivers, trends, opportunities, and restraints. The report also comprises all key details of the global Drug Eluting Balloon for Peripheral Artery Disease market such as market strategies, sales volumes, and consumption. The report also covers the names of all distribution channels such as manufacturers, suppliers, wholesalers, distributors, consumers, and dealers.
QY Research also presents the statistical data in the form of infographics, tables, and charts to predict the trends and developments of the global Drug Eluting Balloon for Peripheral Artery Disease market over the forecast period. The research analysts have also used a framework such as key industry experts interview, research papers, refer journals, survey reports, and face-to-face interviews with expert professionals to know the detailed outlook of the global Drug Eluting Balloon for Peripheral Artery Disease market. The report also includes nautical information, where it shows Drug Eluting Balloon for Peripheral Artery Disease market product volume, utilization value, and production processes.
The research report also consists of a competitive landscape that describes the top players that are functioning in the global Drug Eluting Balloon for Peripheral Artery Disease market. This report also describes the key developments and trends, mergers and acquisitions strategies, and new product innovation that will show an enormous benefit to the companies that are competing in the global Drug Eluting Balloon for Peripheral Artery Disease market.
Geographical Analysis:
Based on region, the global Drug Eluting Balloon for Peripheral Artery Disease market is segmented into North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America). Research analysts have studied government initiatives, changing the political environment, and social scenarios that are likely to contribute to the growth of the regional markets.
Key Players:
The major players that are operating in the global Drug Eluting Balloon for Peripheral Artery Disease market are
Cook Group
BD
Medtronic
Bayer
Opto Circuits
…
Segment by Type
3μg/ mm2
2μg/ mm2
Others
Segment by Application
Hospitals
Ambulatory Surgery Centers
Catheterization Laboratories
Others
Competitive Landscape:
Factors such as cost analysis, marketing strategy, factor analysis, distributors, sourcing strategy, and industrial chain are all the parts of the global Drug Eluting Balloon for Peripheral Artery Disease market. The report also includes the analysis of the return on investment (ROI) feasibility with the estimated SWOT analysis.
The report covers the following objectives:
• Proliferation and maturation of trade in the global Drug Eluting Balloon for Peripheral Artery Disease market.
• The market share of the global Drug Eluting Balloon for Peripheral Artery Disease market, supply and demand ratio, growth revenue, supply chain analysis, and business overview.
• Current and future market trends that are influencing the growth opportunities and growth rate of the global Drug Eluting Balloon for Peripheral Artery Disease market.
• Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the global Drug Eluting Balloon for Peripheral Artery Disease market.
1 Drug Eluting Balloon for Peripheral Artery Disease Market Overview
1.1 Drug Eluting Balloon for Peripheral Artery Disease Product Scope
1.2 Drug Eluting Balloon for Peripheral Artery Disease Segment by Type
1.2.1 Global Drug Eluting Balloon for Peripheral Artery Disease Sales by Type (2020-2026)
1.2.2 3μg/ mm2
1.2.3 2μg/ mm2
1.2.4 Others
1.3 Drug Eluting Balloon for Peripheral Artery Disease Segment by Application
1.3.1 Global Drug Eluting Balloon for Peripheral Artery Disease Sales Comparison by Application (2020-2026)
1.3.2 Hospitals
1.3.3 Ambulatory Surgery Centers
1.3.4 Catheterization Laboratories
1.3.5 Others
1.4 Drug Eluting Balloon for Peripheral Artery Disease Market Estimates and Forecasts (2015-2026)
1.4.1 Global Drug Eluting Balloon for Peripheral Artery Disease Sales Growth Rate (2015-2026)
1.4.2 Global Drug Eluting Balloon for Peripheral Artery Disease Revenue and Growth Rate (2015-2026)
1.4.3 Global Drug Eluting Balloon for Peripheral Artery Disease Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): Drug Eluting Balloon for Peripheral Artery Disease Industry Impact
1.5.1 How the Covid-19 is Affecting the Drug Eluting Balloon for Peripheral Artery Disease Industry
1.5.1.1 Drug Eluting Balloon for Peripheral Artery Disease Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Drug Eluting Balloon for Peripheral Artery Disease Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Drug Eluting Balloon for Peripheral Artery Disease Players to Combat Covid-19 Impact
2 Drug Eluting Balloon for Peripheral Artery Disease Estimate and Forecast by Region
2.1 Global Drug Eluting Balloon for Peripheral Artery Disease Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Drug Eluting Balloon for Peripheral Artery Disease Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share by Region (2015-2020)
2.2.2 Global Drug Eluting Balloon for Peripheral Artery Disease Revenue Market Share by Region (2015-2020)
2.3 Global Drug Eluting Balloon for Peripheral Artery Disease Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Drug Eluting Balloon for Peripheral Artery Disease Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Drug Eluting Balloon for Peripheral Artery Disease Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Drug Eluting Balloon for Peripheral Artery Disease Estimates and Projections (2015-2026)
2.4.2 Europe Drug Eluting Balloon for Peripheral Artery Disease Estimates and Projections (2015-2026)
2.4.3 China Drug Eluting Balloon for Peripheral Artery Disease Estimates and Projections (2015-2026)
2.4.4 Japan Drug Eluting Balloon for Peripheral Artery Disease Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Drug Eluting Balloon for Peripheral Artery Disease Estimates and Projections (2015-2026)
2.4.6 India Drug Eluting Balloon for Peripheral Artery Disease Estimates and Projections (2015-2026)
3 Global Drug Eluting Balloon for Peripheral Artery Disease Competition Landscape by Players
3.1 Global Top Drug Eluting Balloon for Peripheral Artery Disease Players by Sales (2015-2020)
3.2 Global Top Drug Eluting Balloon for Peripheral Artery Disease Players by Revenue (2015-2020)
3.3 Global Drug Eluting Balloon for Peripheral Artery Disease Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Drug Eluting Balloon for Peripheral Artery Disease as of 2019)
3.4 Global Drug Eluting Balloon for Peripheral Artery Disease Average Price by Company (2015-2020)
3.5 Manufacturers Drug Eluting Balloon for Peripheral Artery Disease Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Drug Eluting Balloon for Peripheral Artery Disease Players (Opinion Leaders)
4 Global Drug Eluting Balloon for Peripheral Artery Disease Market Size by Type
4.1 Global Drug Eluting Balloon for Peripheral Artery Disease Historic Market Review by Type (2015-2020)
4.1.1 Global Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share by Type (2015-2020)
4.1.2 Global Drug Eluting Balloon for Peripheral Artery Disease Revenue Market Share by Type (2015-2020)
4.1.3 Global Drug Eluting Balloon for Peripheral Artery Disease Price by Type (2014-2020)
4.2 Global Drug Eluting Balloon for Peripheral Artery Disease Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Drug Eluting Balloon for Peripheral Artery Disease Sales Forecast by Type (2021-2026)
4.2.2 Global Drug Eluting Balloon for Peripheral Artery Disease Revenue Forecast by Type (2021-2026)
4.2.3 Global Drug Eluting Balloon for Peripheral Artery Disease Price Forecast by Type (2021-2026)
5 Global Drug Eluting Balloon for Peripheral Artery Disease Market Size by Application
5.1 Global Drug Eluting Balloon for Peripheral Artery Disease Historic Market Review by Application (2015-2020)
5.1.1 Global Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share by Application (2015-2020)
5.1.2 Global Drug Eluting Balloon for Peripheral Artery Disease Revenue Market Share by Application (2015-2020)
5.1.3 Global Drug Eluting Balloon for Peripheral Artery Disease Price by Application (2015-2020)
5.2 Global Drug Eluting Balloon for Peripheral Artery Disease Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Drug Eluting Balloon for Peripheral Artery Disease Sales Forecast by Application (2021-2026)
5.2.2 Global Drug Eluting Balloon for Peripheral Artery Disease Revenue Forecast by Application (2021-2026)
5.2.3 Global Drug Eluting Balloon for Peripheral Artery Disease Price Forecast by Application (2021-2026)
3 North America Drug Eluting Balloon for Peripheral Artery Disease Market Facts & Figures
3.2 North America Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share by Company (2015-2020)
3.3 North America Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share by Type (2015-2020)
3.4 North America Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share by Application (2015-2020)
4 Europe Drug Eluting Balloon for Peripheral Artery Disease Market Facts & Figures
4.2 Europe Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share by Company (2015-2020)
4.3 Europe Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share by Type (2015-2020)
4.4 Europe Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share by Application (2015-2020)
5 China Drug Eluting Balloon for Peripheral Artery Disease Market Facts & Figures
5.2 China Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share by Company (2015-2020)
5.3 China Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share by Type (2015-2020)
5.4 China Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share by Application (2015-2020)
6 Japan Drug Eluting Balloon for Peripheral Artery Disease Market Facts & Figures
6.2 Japan Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share by Company (2015-2020)
6.3 Japan Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share by Type (2015-2020)
6.4 Japan Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share by Application (2015-2020)
7 Southeast Asia Drug Eluting Balloon for Peripheral Artery Disease Market Facts & Figures
7.2 Southeast Asia Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share by Application (2015-2020)
8 India Drug Eluting Balloon for Peripheral Artery Disease Market Facts & Figures
8.2 India Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share by Company (2015-2020)
8.3 India Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share by Type (2015-2020)
8.4 India Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Drug Eluting Balloon for Peripheral Artery Disease Business
12.1 Cook Group
12.1.1 Cook Group Drug Eluting Balloon for Peripheral Artery Disease Corporation Information
12.1.2 Cook Group Drug Eluting Balloon for Peripheral Artery Disease Business Overview and Total Revenue
12.1.3 Cook Group Drug Eluting Balloon for Peripheral Artery Disease Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Cook Group Drug Eluting Balloon for Peripheral Artery Disease Products Offered
12.1.5 Cook Group Recent Development
12.2 BD
12.2.1 BD Drug Eluting Balloon for Peripheral Artery Disease Corporation Information
12.2.2 BD Drug Eluting Balloon for Peripheral Artery Disease Business Overview and Total Revenue
12.2.3 BD Drug Eluting Balloon for Peripheral Artery Disease Sales, Revenue and Gross Margin (2015-2020)
12.2.4 BD Drug Eluting Balloon for Peripheral Artery Disease Products Offered
12.2.5 BD Recent Development
12.3 Medtronic
12.3.1 Medtronic Drug Eluting Balloon for Peripheral Artery Disease Corporation Information
12.3.2 Medtronic Drug Eluting Balloon for Peripheral Artery Disease Business Overview and Total Revenue
12.3.3 Medtronic Drug Eluting Balloon for Peripheral Artery Disease Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Medtronic Drug Eluting Balloon for Peripheral Artery Disease Products Offered
12.3.5 Medtronic Recent Development
12.4 Bayer
12.4.1 Bayer Drug Eluting Balloon for Peripheral Artery Disease Corporation Information
12.4.2 Bayer Drug Eluting Balloon for Peripheral Artery Disease Business Overview and Total Revenue
12.4.3 Bayer Drug Eluting Balloon for Peripheral Artery Disease Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Bayer Drug Eluting Balloon for Peripheral Artery Disease Products Offered
12.4.5 Bayer Recent Development
12.5 Opto Circuits
12.5.1 Opto Circuits Drug Eluting Balloon for Peripheral Artery Disease Corporation Information
12.5.2 Opto Circuits Drug Eluting Balloon for Peripheral Artery Disease Business Overview and Total Revenue
12.5.3 Opto Circuits Drug Eluting Balloon for Peripheral Artery Disease Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Opto Circuits Drug Eluting Balloon for Peripheral Artery Disease Products Offered
12.5.5 Opto Circuits Recent Development
…
13 Drug Eluting Balloon for Peripheral Artery Disease Manufacturing Cost Analysis
13.1 Drug Eluting Balloon for Peripheral Artery Disease Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Drug Eluting Balloon for Peripheral Artery Disease
13.4 Drug Eluting Balloon for Peripheral Artery Disease Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Drug Eluting Balloon for Peripheral Artery Disease Distributors List
14.3 Drug Eluting Balloon for Peripheral Artery Disease Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Drug Eluting Balloon for Peripheral Artery Disease Sales (K Units) Growth Rate by Type (2020-2026)
Table 2. Global Drug Eluting Balloon for Peripheral Artery Disease Sales (K Units) Comparison by Application (2020-2026)
Table 3. COVID-19 Impact Global Market: (Four Drug Eluting Balloon for Peripheral Artery Disease Market Size Forecast Scenarios)
Table 4. Opportunities and Trends for Drug Eluting Balloon for Peripheral Artery Disease Players in the COVID-19 Landscape
Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 6. Key Regions/Countries Measures against Covid-19 Impact
Table 7. Proposal for Drug Eluting Balloon for Peripheral Artery Disease Players to Combat Covid-19 Impact
Table 8. Global Market Drug Eluting Balloon for Peripheral Artery Disease Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 9. Global Drug Eluting Balloon for Peripheral Artery Disease Sales (K Units) by Region (2015-2020)
Table 10. Global Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share by Region (2015-2020)
Table 11. Global Drug Eluting Balloon for Peripheral Artery Disease Revenue (US$ Million) Market Share by Region (2015-2020))
Table 12. Global Drug Eluting Balloon for Peripheral Artery Disease Revenue Share by Region (2015-2020)
Table 13. Global Drug Eluting Balloon for Peripheral Artery Disease Sales (K Units) Forecast by Region (2021-2026)
Table 14. Global Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share Forecast by Region (2021-2026)
Table 15. Global Drug Eluting Balloon for Peripheral Artery Disease Revenue (US$ Million) Forecast by Region (2021-2026)
Table 16. Global Drug Eluting Balloon for Peripheral Artery Disease Revenue Share Forecast by Region (2021-2026)
Table 17. Global Drug Eluting Balloon for Peripheral Artery Disease (K Units) of Key Companies (2015-2020)
Table 18. Global Drug Eluting Balloon for Peripheral Artery Disease Sales Share by Company (2015-2020)
Table 19. Global Drug Eluting Balloon for Peripheral Artery Disease Revenue (US$ Million) by Company (2015-2020)
Table 20. Global Drug Eluting Balloon for Peripheral Artery Disease Revenue Share by Company (2015-2020)
Table 21. Global Drug Eluting Balloon for Peripheral Artery Disease by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Drug Eluting Balloon for Peripheral Artery Disease as of 2019)
Table 22. Global Drug Eluting Balloon for Peripheral Artery Disease Average Price (USD/Unit) of Key Company (2015-2020)
Table 23. Manufacturers Drug Eluting Balloon for Peripheral Artery Disease Manufacturing Sites and Area Served
Table 24. Manufacturers Drug Eluting Balloon for Peripheral Artery Disease Product Type
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Main Points Interviewed from Key Drug Eluting Balloon for Peripheral Artery Disease Players
Table 27. Global Drug Eluting Balloon for Peripheral Artery Disease Sales (K Units) by Type (2015-2020)
Table 28. Global Drug Eluting Balloon for Peripheral Artery Disease Sales Share by Type (2015-2020)
Table 29. Global Drug Eluting Balloon for Peripheral Artery Disease Revenue (US$ Million) Market Share by Type (2015-2020)
Table 30. Global Drug Eluting Balloon for Peripheral Artery Disease Price (K Units) by Type (2015-2020)
Table 31. Global Drug Eluting Balloon for Peripheral Artery Disease Sales Share by Type (2021-2026)
Table 32. Global Drug Eluting Balloon for Peripheral Artery Disease Revenue (US$ Million) Market Share by Type (2021-2026)
Table 33. Global Drug Eluting Balloon for Peripheral Artery Disease Revenue Share by Type (2021-2026)
Table 34. Global Drug Eluting Balloon for Peripheral Artery Disease Price (K Units) by Type (2021-2026)
Table 35. Global Drug Eluting Balloon for Peripheral Artery Disease Sales (K Units) by Application (2015-2020)
Table 36. Global Drug Eluting Balloon for Peripheral Artery Disease Sales Share by Application (2015-2020)
Table 37. Global Drug Eluting Balloon for Peripheral Artery Disease Revenue (US$ Million) Market Share by Application (2015-2020)
Table 38. Global Drug Eluting Balloon for Peripheral Artery Disease Price (K Units) by Application (2015-2020)
Table 39. Global Drug Eluting Balloon for Peripheral Artery Disease Sales (K Units) by Application (2021-2026)
Table 40. Global Drug Eluting Balloon for Peripheral Artery Disease Sales Share by Application (2021-2026)
Table 41. Global Drug Eluting Balloon for Peripheral Artery Disease Revenue (US$ Million) Market Share by Application (2021-2026)
Table 42. Global Drug Eluting Balloon for Peripheral Artery Disease Revenue Share by Application (2021-2026)
Table 43. Global Drug Eluting Balloon for Peripheral Artery Disease Price (K Units) by Application (2021-2026)
Table 44. United States Drug Eluting Balloon for Peripheral Artery Disease Sales (K Units) by Company (2015-2020)
Table 45. United States Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share by Company (2015-2020)
Table 46. United States Drug Eluting Balloon for Peripheral Artery Disease Sales (K Units) by Type (2015-2020)
Table 47. United States Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share by Type (2015-2020)
Table 48. United States Drug Eluting Balloon for Peripheral Artery Disease Sales (K Units) by Application (2015-2020)
Table 49. United States Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share by Application (2015-2020)
Table 50. Europe Drug Eluting Balloon for Peripheral Artery Disease Sales (K Units) by Company (2015-2020)
Table 51. Europe Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share by Company (2015-2020)
Table 52. Europe Drug Eluting Balloon for Peripheral Artery Disease Sales (K Units) by Type (2015-2020)
Table 53. Europe Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share by Type (2015-2020)
Table 54. Europe Drug Eluting Balloon for Peripheral Artery Disease Sales (K Units) by Application (2015-2020)
Table 55. Europe Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share by Type (2015-2020)
Table 56. China Drug Eluting Balloon for Peripheral Artery Disease Sales (K Units) by Company (2015-2020)
Table 57. China Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share by Company (2015-2020)
Table 58. China Drug Eluting Balloon for Peripheral Artery Disease Sales (K Units) by Type (2015-2020)
Table 59. China Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share by Type (2015-2020)
Table 60. China Drug Eluting Balloon for Peripheral Artery Disease Sales (K Units) by Application (2015-2020)
Table 61. China Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share by Application (2015-2020)
Table 62. Japan Drug Eluting Balloon for Peripheral Artery Disease Sales (K Units) by Company (2015-2020)
Table 63. Japan Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share by Company (2015-2020)
Table 64. Japan Drug Eluting Balloon for Peripheral Artery Disease Sales (K Units) by Type (2015-2020)
Table 65. Japan Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share by Type (2015-2020)
Table 66. Japan Drug Eluting Balloon for Peripheral Artery Disease Sales (K Units) by Application (2015-2020)
Table 67. Japan Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share by Application (2015-2020)
Table 68. Southeast Asia Drug Eluting Balloon for Peripheral Artery Disease Sales (K Units) by Company (2015-2020)
Table 69. Southeast Asia Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share by Company (2015-2020)
Table 70. Southeast Asia Drug Eluting Balloon for Peripheral Artery Disease Sales (K Units) by Type (2015-2020)
Table 71. Southeast Asia Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share by Type (2015-2020)
Table 72. Southeast Asia Drug Eluting Balloon for Peripheral Artery Disease Sales (K Units) by Type (2015-2020)
Table 73. Southeast Asia Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share by Application (2015-2020)
Table 74. India Drug Eluting Balloon for Peripheral Artery Disease Sales (K Units) by Company (2015-2020)
Table 75. India Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share by Company (2015-2020)
Table 76. India Drug Eluting Balloon for Peripheral Artery Disease Sales (K Units) by Type (2015-2020)
Table 77. India Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share by Type (2015-2020)
Table 78. India Drug Eluting Balloon for Peripheral Artery Disease Sales (K Units) by Application (2015-2020)
Table 79. India Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share by Application (2015-2020)
Table 80. Cook Group Corporation Information
Table 81. Cook Group Description and Business Overview
Table 82. Cook Group Drug Eluting Balloon for Peripheral Artery Disease Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. Cook Group Drug Eluting Balloon for Peripheral Artery Disease Product
Table 84. Cook Group Recent Development
Table 85. BD Corporation Information
Table 86. BD Description and Business Overview
Table 87. BD Drug Eluting Balloon for Peripheral Artery Disease Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. BD Drug Eluting Balloon for Peripheral Artery Disease Product
Table 89. BD Recent Development
Table 90. Medtronic Corporation Information
Table 91. Medtronic Description and Business Overview
Table 92. Medtronic Drug Eluting Balloon for Peripheral Artery Disease Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. Medtronic Drug Eluting Balloon for Peripheral Artery Disease Product
Table 94. Medtronic Recent Development
Table 95. Bayer Corporation Information
Table 96. Bayer Description and Business Overview
Table 97. Bayer Drug Eluting Balloon for Peripheral Artery Disease Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. Bayer Drug Eluting Balloon for Peripheral Artery Disease Product
Table 99. Bayer Recent Development
Table . Opto Circuits Corporation Information
Table . Opto Circuits Description and Business Overview
Table . Opto Circuits Drug Eluting Balloon for Peripheral Artery Disease Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table . Opto Circuits Drug Eluting Balloon for Peripheral Artery Disease Product
Table . Opto Circuits Recent Development
Table 105. Production Base and Market Concentration Rate of Raw Material
Table 106. Key Suppliers of Raw Materials
Table 107. Drug Eluting Balloon for Peripheral Artery Disease Distributors List
Table 108. Drug Eluting Balloon for Peripheral Artery Disease Customers List
Table 109. Market Key Trends
Table 110. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 111. Key Challenges
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
List of Figures
Figure 1. Drug Eluting Balloon for Peripheral Artery Disease Product Picture
Figure 2. Global Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Drug Eluting Balloon for Peripheral Artery Disease Market Share by Application in 2020 & 2026
Figure 6. Hospitals Examples
Figure 7. Ambulatory Surgery Centers Examples
Figure 8. Catheterization Laboratories Examples
Figure 9. Others Examples
Figure 10. Global Drug Eluting Balloon for Peripheral Artery Disease Sales (K Units) Growth Rate (2015-2026)
Figure 11. Global Drug Eluting Balloon for Peripheral Artery Disease Revenue (US$ Million) Growth Rate (2015-2026)
Figure 12. Global Drug Eluting Balloon for Peripheral Artery Disease Price Trends Growth Rate (2015-2026) (USD/Unit)
Figure 13. Global Drug Eluting Balloon for Peripheral Artery Disease Revenue Market Share by Region: 2015 VS 2020
Figure 14. Global Drug Eluting Balloon for Peripheral Artery Disease Revenue Market Share by Region: 2021 VS 2026
Figure 15. United States Drug Eluting Balloon for Peripheral Artery Disease Revenue (Million USD) Growth Rate (2015-2026)
Figure 16. United States Drug Eluting Balloon for Peripheral Artery Disease Sales (K Units) Growth Rate (2015-2026)
Figure 17. Europe Drug Eluting Balloon for Peripheral Artery Disease Revenue (Million USD) Growth Rate (2015-2026)
Figure 18. Europe Drug Eluting Balloon for Peripheral Artery Disease Sales (Million USD) Growth Rate (2015-2026)
Figure 19. China Drug Eluting Balloon for Peripheral Artery Disease Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. China Drug Eluting Balloon for Peripheral Artery Disease Sales (Million USD) and Growth Rate (2015-2026)
Figure 21. Japan Drug Eluting Balloon for Peripheral Artery Disease Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. Japan Drug Eluting Balloon for Peripheral Artery Disease Sales (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Drug Eluting Balloon for Peripheral Artery Disease Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. Southeast Asia Drug Eluting Balloon for Peripheral Artery Disease Sales (Million USD) Growth Rate (2015-2026)
Figure 25. India Drug Eluting Balloon for Peripheral Artery Disease Revenue (Million USD) Growth Rate (2015-2026)
Figure 26. India Drug Eluting Balloon for Peripheral Artery Disease Sales (Million USD) Growth Rate (2015-2026)
Figure 27. Global 5 Largest Drug Eluting Balloon for Peripheral Artery Disease Players Market Share by Revenue in Drug Eluting Balloon for Peripheral Artery Disease 2015 & 2019
Figure 28. Drug Eluting Balloon for Peripheral Artery Disease Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 29. Global Drug Eluting Balloon for Peripheral Artery Disease Revenue Share by Type (2015-2020)
Figure 30. Global Drug Eluting Balloon for Peripheral Artery Disease Revenue Growth Rate by Type in 2015 & 2019
Figure 31. Global Drug Eluting Balloon for Peripheral Artery Disease Revenue Share by Application (2015-2020)
Figure 32. Global Drug Eluting Balloon for Peripheral Artery Disease Revenue Growth Rate by Application in 2015 & 2019
Figure 33. United States Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share by Type in 2019
Figure 34. United States Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share by Type in 2019
Figure 35. Europe Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share by Company in 2019
Figure 36. Europe Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share by Type in 2019
Figure 37. Europe Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share by Application in 2019
Figure 38. China Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share by Company in 2019
Figure 39. China Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share by Type in 2019
Figure 40. China Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share by Application in 2019
Figure 41. Japan Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share by Company in 2019
Figure 42. Japan Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share by Type in 2019
Figure 43. Japan Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share by Application in 2019
Figure 44. Southeast Asia Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share by Company in 2019
Figure 45. Southeast Asia Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share by Type in 2019
Figure 46. Southeast Asia Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share by Application in 2019
Figure 47. India Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share by Company in 2019
Figure 48. India Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share by Type in 2019
Figure 49. India Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share by Application in 2019
Figure 50. Cook Group Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. BD Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Medtronic Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Bayer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Opto Circuits Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Key Raw Materials Price Trend
Figure 56. Manufacturing Cost Structure of Drug Eluting Balloon for Peripheral Artery Disease
Figure 57. Manufacturing Process Analysis of Drug Eluting Balloon for Peripheral Artery Disease
Figure 58. Drug Eluting Balloon for Peripheral Artery Disease Industrial Chain Analysis
Figure 59. Channels of Distribution
Figure 60. Distributors Profiles
Figure 61. Porter's Five Forces Analysis
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed